WO2013019762A4 - Filamentous bioresorbable stent - Google Patents

Filamentous bioresorbable stent Download PDF

Info

Publication number
WO2013019762A4
WO2013019762A4 PCT/US2012/048912 US2012048912W WO2013019762A4 WO 2013019762 A4 WO2013019762 A4 WO 2013019762A4 US 2012048912 W US2012048912 W US 2012048912W WO 2013019762 A4 WO2013019762 A4 WO 2013019762A4
Authority
WO
WIPO (PCT)
Prior art keywords
filaments
endoprosthesis
filament
stents
stent
Prior art date
Application number
PCT/US2012/048912
Other languages
French (fr)
Other versions
WO2013019762A2 (en
WO2013019762A3 (en
Inventor
Catherine Ann SCANLON
Original Assignee
SCANLON, John, James
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SCANLON, John, James filed Critical SCANLON, John, James
Publication of WO2013019762A2 publication Critical patent/WO2013019762A2/en
Publication of WO2013019762A3 publication Critical patent/WO2013019762A3/en
Publication of WO2013019762A4 publication Critical patent/WO2013019762A4/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0077Special surfaces of prostheses, e.g. for improving ingrowth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0004Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/003Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in adsorbability or resorbability, i.e. in adsorption or resorption time
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067Means for introducing or releasing pharmaceutical products into the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

Disclosed herein is a high radial strength, filament-reinforced bioresorbable stent comprising extruding a polymer into one or more small diameter filaments; stretching the extruded filaments to an optimum longer length; organizing one or more of the stretched filaments into a tubular shape; thermoforming the tubular shaped filaments to substantially retain a tubular shape; binding the filaments together with one or more bioresorbable polymers to produce a filament-reinforced tube; fabricating a stent from the filament-reinforced tube by cutting a strut pattern in the wall thickness of the tube; covering the stent with coating to delay hydrolysis and/or deliver an active ingredient to minimize the risk of restenosis; crimping the stent onto a balloon catheter assembly; delivering the stent into an anatomical lumen via percutaneous methods to a treatment location; expanding the stent at the treatment location wherein the stent temporarily supports the anatomical lumen; and removing the catheter from the lumen.

Claims

AMENDED CLAIMS
received by the International Bureau on 12 February 2013 (12.02.2013)
Claim 1. An endoprosthesis comprising:
A hollow, elongated, body including a wall thickness formed of at least one layer of one or more filaments positioned on an outer surface of a tubular-shaped mandrel,
Wherein said filaments and mandrel comprise one or more materials of the same or different chemical composition or molecular weight;
Wherein said filament or filaments are positioned in said wall thickness of said body in an axial orientation, a circumferential orientation, an angled orientation or combination thereof orientation relative to the central axis of the body;
Wherein said filament or filaments are of one or more thicknesses,
Wherein said body includes a pattern of openings partially or fully surrounded by interconnecting struts of any repeating or non-repeating geometric pattern;
Wherein said struts comprise multiple filament sections and mandrel sections after inclusion of said openings in said body; and
Wherein said material or materials maintain sufficient strength to hold open an anatomical lumen from the time of deployment of said endoprosthesis until the end of a treatment time, at which time said material or materials undergo degradation resulting in a loss of said strength and with longer time said material is substantially broken down into byproducts that undergo partial or full resorption by a living body.
Claim 2. The endoprosthesis of claim 1 includes one or more coatings of the same or different chemical composition on the endoprosthesis abluminal surface, endoprosthesis luminal surface, endoprosthesis cutting edges, one or more filament surfaces, or combinations thereof.
Claim 3. The endoprosthesis of claim 1 includes at least a partial thermal fusion between said severed filaments at a position near the cutting edges of said struts to at least partially attach the ends of the filaments together near the cutting edges.
Claim 4. The endoprosthesis of claim 1 includes one or more active ingredients of the same or different composition.
Claim 5. The endoprosthesis of claim 1 includes at least one layer of a binding material that connects one or more filaments or layers of filaments wherein the binding material is positioned on the inner surface of a filament layer, outer surface of a filament layer, between filament layers, between adjacent filaments, between adjacent multi-filaments, or combinations thereof.
Claim 6. The endoprosthesis of claim 1 includes an application selected from the group of: coronary vascular stents, carotid stents, peripheral vascular stents, renal stents, iliac stents, superficial femoral artery stents, cerebral stents, urinary stents (urethral and ureteral stents), biliary stents, tracheal stents, gastrointestinal stents, esophageal stents, and drug delivery device.
Claim 7. The endoprosthesis of claim 1 includes a stent-to-anatomical lumen coverage ratio of less than 75 percent. Claim 8. The endoprosthesis of claim 1 includes a strut thickness less than 0.15 mm. Claim 9. The endoprosthesis of claim 1 includes a radial strength of greater than 0.05 MPar(400 mmHg).
Claim 10. The endoprosthesis of claim 1 includes filaments organized in said wall thickness by one or more processes selected from the group of: braiding, winding, weaving, crocheting, interlacing, nonwoven, spun bond, fibrillating, flash spun, or knitting said filaments.
Claim 11. The binding material of claim 5 has a thickness ranging from 0.0001 to 0.2000 mm.
ClaimJ2. The filament of claim 1 has a thickness ranging from 0,05 to 150 microns. Claim 13. The filament of claim 1 has a tensile strength greater than 70 MPa (10,500 psi).
Claim 14* The endoprosthesis of claim 1 includes at least one malleable wire comprised of bioresorbable material.
Claim 15. The endoprosthesis of claim 1 includes filaments that degrade and lose mass at different rates.
Claim 16. The coating of claim 2 delays the onset of degradation of said material by greater than 1 week at physiological conditions.
Claim 17. The coating of claim 2 includes a storage and a delivery of at least one therapeutic drug of the same or different composition to said anatomical lumen. Claim 18. The endoprosthesis of claim 1 includes one or more additives, nano sized additives, or combinations thereof.
Claim 19 (the claim is canceled).
Claim 20 (the claim is cancelled).
Claim 21. The filament or filaments of claim 1 are a straight, curved, bent, or combination thereof shape,
Claim 22. The filament or filaments of claim 1 are positioned on a mandrel comprised of oriented or extended molecular chain material having a solid or porous wall thickness prior to cutting said pattern of openings into said tubular-shaped body.
PCT/US2012/048912 2011-07-31 2012-07-31 Filamentous bioresorbable stent WO2013019762A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161513631P 2011-07-31 2011-07-31
US61/513,631 2011-07-31

Publications (3)

Publication Number Publication Date
WO2013019762A2 WO2013019762A2 (en) 2013-02-07
WO2013019762A3 WO2013019762A3 (en) 2013-02-28
WO2013019762A4 true WO2013019762A4 (en) 2013-03-21

Family

ID=47629882

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/048912 WO2013019762A2 (en) 2011-07-31 2012-07-31 Filamentous bioresorbable stent

Country Status (1)

Country Link
WO (1) WO2013019762A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8150519B2 (en) 2002-04-08 2012-04-03 Ardian, Inc. Methods and apparatus for bilateral renal neuromodulation
CN104353129A (en) * 2014-10-23 2015-02-18 上海百心安生物技术有限公司 Intravascular stent and preparation method thereof
WO2019149680A1 (en) 2018-01-31 2019-08-08 Teijin Aramid B.V. Catheter tubular shaft

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8501079B2 (en) * 2009-09-14 2013-08-06 Abbott Cardiovascular Systems Inc. Controlling crystalline morphology of a bioabsorbable stent
US8585753B2 (en) * 2006-03-04 2013-11-19 John James Scanlon Fibrillated biodegradable prosthesis
WO2008005898A2 (en) * 2006-06-30 2008-01-10 Ev3 Endovascular, Inc. Medical devices with amorphous metals and methods therefor
US7794495B2 (en) * 2006-07-17 2010-09-14 Advanced Cardiovascular Systems, Inc. Controlled degradation of stents

Also Published As

Publication number Publication date
WO2013019762A2 (en) 2013-02-07
WO2013019762A3 (en) 2013-02-28

Similar Documents

Publication Publication Date Title
US20080200979A1 (en) Anti-restenotic therapeutic device
EP3384878B1 (en) A method of making a self-expanding implant
US7108716B2 (en) Stent-graft with bioabsorbable structural support
JP5526038B2 (en) Stent with anti-migration feature
US10154917B2 (en) Helical and segmented stent-graft
US8540765B2 (en) Medical implant
CA2529494A1 (en) Polymeric stent and method of manufacture
WO2011008883A1 (en) Biodegradable self-expanding prosthesis
GB2475778A (en) Implantable medical device comprising a self-expanding tubular structure
WO2013019762A4 (en) Filamentous bioresorbable stent
JPWO2009072172A1 (en) Stent and manufacturing method thereof
US20080119924A1 (en) Laminated stent graft edge binding
WO2014172319A1 (en) Drug eluting medical implant
WO2013158619A2 (en) Drug eluting medical implant

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12819480

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct app. not ent. europ. phase

Ref document number: 12819480

Country of ref document: EP

Kind code of ref document: A2